NM_181703.4(GJA5):c.170T>G (p.Ile57Ser) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Oct 5, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003169916.1

Allele description [Variation Report for NM_181703.4(GJA5):c.170T>G (p.Ile57Ser)]

NM_181703.4(GJA5):c.170T>G (p.Ile57Ser)

Gene:

GJA5:gap junction protein alpha 5 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1q21.2

Genomic location:

Preferred name:

NM_181703.4(GJA5):c.170T>G (p.Ile57Ser)

HGVS:

NC_000001.11:g.147759069A>C
NG_009369.2:g.19306T>G
NM_005266.5:c.170T>G
NM_005266.7:c.170T>G
NM_181703.4:c.170T>GMANE SELECT
NP_005257.2:p.Ile57Ser
NP_859054.1:p.Ile57Ser
NC_000001.10:g.147231177A>C

Protein change:

I57S

Links:

dbSNP: rs1553227077

NCBI 1000 Genomes Browser:

rs1553227077

Molecular consequence:

NM_005266.7:c.170T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_181703.4:c.170T>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

putative Xaa-Pro aminopeptidase 3, partial [Euoplos mcmillani]
putative Xaa-Pro aminopeptidase 3, partial [Euoplos mcmillani]
gi|1142968774|gb|AQM32461.1|

Protein
putative ribosome production factor 2, partial [Euoplos mcmillani]
putative ribosome production factor 2, partial [Euoplos mcmillani]
gi|1142968466|gb|AQM32307.1|

Protein
MAPK and MTOR activator 3, partial [Oceanodroma leucorhoa]
MAPK and MTOR activator 3, partial [Oceanodroma leucorhoa]
gi|2062395515|gb|QXF78317.1|

Protein
MAPK and MTOR activator 3, partial [Pelecanus erythrorhynchos]
MAPK and MTOR activator 3, partial [Pelecanus erythrorhynchos]
gi|2062395506|gb|QXF78313.1|

Protein
MAPK and MTOR activator 3, partial [Buteo jamaicensis]
MAPK and MTOR activator 3, partial [Buteo jamaicensis]
gi|2062395495|gb|QXF78308.1|

Protein

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV003914881	GeneDx	criteria provided, single submitter (GeneDx Variant Classification Process June 2021)	Uncertain significance (Oct 5, 2022)	germline	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV003914881

GeneDx

criteria provided, single submitter

(GeneDx Variant Classification Process June 2021)

Uncertain significance
(Oct 5, 2022)

germline

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	yes	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From GeneDx, SCV003914881.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

Has not been previously published as pathogenic or benign to our knowledge; Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	yes	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine